Literature DB >> 12106348

Differential Regulation of Nerve Growth Factor (NGF) Synthesis in Neurons and Astrocytes by Glucocorticoid Hormones.

Dan Lindholm1, Eero Castrén, Bastian Hengerer, Francisco Zafra, Benedikt Berninger, Hans Thoenen.   

Abstract

Glucocorticoid hormones are important regulators of brain development and ageing. Here we show that dexamethasone, a synthetic glucocorticoid, differentially affects the expression of nerve growth factor (NGF) in cultured neurons and astrocytes. Dexamethasone increased the levels of NGF mRNA in cultured hippocampal neurons in a time- and concentration-dependent manner, whereas it down-regulated the NGF mRNA levels in astrocytes. However, dexamethasone had no effect on the mRNA levels of brain-derived neurotrophic factor in the hippocampal neurons. Aldosterone, a mineralocorticoid, in higher concentrations also up-regulated NGF mRNA levels in the hippocampal neurons. Dexamethasone increased the levels of NGF mRNA in the rat hippocampus in vivo, but not to the same extent as observed with kainic acid, a glutamate receptor agonist. There is no apparent diurnal rhythm in the hippocampal NGF protein levels corresponding to circadian variations in the levels of glucocorticoid hormones in serum. The increase in NGF mRNA in the hippocampus in vivo following dexamethasone treatments may reflect the physiological response of hippocampal neurons to high glucocorticoid levels reached under conditions of stress.

Entities:  

Year:  1992        PMID: 12106348     DOI: 10.1111/j.1460-9568.1992.tb00889.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  14 in total

Review 1.  Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.

Authors:  Zhongwu Liu; Michael Chopp
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

Review 2.  Glucocorticoids and the hippocampus. Developmental interactions facilitating the expression of behavioral inhibition.

Authors:  L K Takahashi
Journal:  Mol Neurobiol       Date:  1996-12       Impact factor: 5.590

3.  Glucocorticoid-Induced Reductions of Myelination and Connexin 43 in Mixed Central Nervous System Cell Cultures Are Prevented by Mifepristone.

Authors:  José Javier Miguel-Hidalgo; Kathleen Carter; Preston Hardin Deloach; Leon Sanders; Yi Pang
Journal:  Neuroscience       Date:  2019-06-01       Impact factor: 3.590

Review 4.  Adrenal steroids and plasticity of hippocampal neurons: toward an understanding of underlying cellular and molecular mechanisms.

Authors:  B S McEwen; H Cameron; H M Chao; E Gould; A M Magarinos; Y Watanabe; C S Woolley
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

5.  Glucocorticoid regulation of motoneuronal parameters in rats with spinal cord injury.

Authors:  S L Gonzalez; F Saravia; M C Gonzalez Deniselle; A E Lima; A F De Nicola
Journal:  Cell Mol Neurobiol       Date:  1999-10       Impact factor: 5.046

6.  Light regulates expression of brain-derived neurotrophic factor mRNA in rat visual cortex.

Authors:  E Castrén; F Zafra; H Thoenen; D Lindholm
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

Review 7.  Regulation of neuropeptide expression in the brain by neurotrophins. Potential role in vivo.

Authors:  J Carnahan; H Nawa
Journal:  Mol Neurobiol       Date:  1995 Apr-Jun       Impact factor: 5.590

Review 8.  Corticosteroids and perinatal hypoxic-ischemic brain injury.

Authors:  Katherine R Concepcion; Lubo Zhang
Journal:  Drug Discov Today       Date:  2018-05-17       Impact factor: 7.851

Review 9.  Activity-dependent dendritic release of BDNF and biological consequences.

Authors:  Nicola Kuczewski; Christophe Porcher; Volkmar Lessmann; Igor Medina; Jean-Luc Gaiarsa
Journal:  Mol Neurobiol       Date:  2009-01-22       Impact factor: 5.590

10.  Nerve growth factor induces process formation in meningeal cells: implications for scar formation in the injured CNS.

Authors:  J Frisén; M Risling; L Korhonen; U Zirrgiebel; C B Johansson; S Cullheim; D Lindholm
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.